Top 50 Health Care Angel Investors in Israel (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Marius Nacht
Angel
|
5 | Israel, United States, Germany | Series A, Seed, Series B | Artificial Intelligence, Health Care, Machine Learning | $3M–$120M |
|
Ran Tuttnauer
Angel
|
3 | Israel, Canada, United States | Seed, Series A | Health Care, Big Data, Internet | |
|
Howard Morgan
Angel
|
3 | United States, Israel, India | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care | $857k–$85M |
|
Zohar Gilon
Angel
|
3 | Israel, United States | Seed, Series A, Series B | Software, Internet, Health Care | $1.5M–$15M |
|
David Golan
Angel
|
2 | Israel, United States | Seed, Series A | Health Care, Software, Wellness | |
|
Danny Hadar
Angel
|
2 | Israel, United States | Seed, Series B | Software, Artificial Intelligence, Internet | $65k–$11M |
|
Avishai Abrahami
Angel
|
2 | Israel, United States, Italy | Seed, Pre-Seed, Series A | Software, Information Technology, Artificial Intelligence | $250k–$35M |
|
Moshe Gaon
Angel
|
2 | Israel, United States | Seed, Series A, Convertible Note | Advertising, SaaS, Music | |
|
Eyal Gura
Angel
|
2 | United States, Israel, Belgium | Series A, Seed, Series B | Software, Mobile, Health Care | $1M–$40M |
|
Jonathan Karten
Angel
|
2 | Israel, United States, Canada | Seed, Angel, Pre-Seed | Software, B2B, Marketing | $100k–$10M |
|
Yehuda Zisapel
Angel
|
2 | Israel | Series A, Seed | Medical Device, Medical, Health Care | |
|
Oren Dobronsky
Angel
|
2 | United States, Israel | Seed, Series A, Angel | FinTech, Payments, Software | $1M–$17M |
|
Mazal CB
Angel
|
2 | Israel | Seed, Pre-Seed | Health Care, Therapeutics, Medical Device | |
|
Sir Ronald Cohen
Angel
|
2 | Israel, United States, United Kingdom | Series A, Seed | Health Care, Financial Services, Apps | $1.7M–$100M |
|
Jordan Feiger
Angel
|
2 | Israel | Seed, Series A | Medical, Health Care, Medical Device | |
|
Prof. Rafael Beyar
Angel
|
2 | Israel | Series A, Seed | Medical Device, Medical, Machine Learning | $1M–$17M |
|
Shimon Eckhouse
Angel
|
2 | Israel | Seed | Medical, Biotechnology, Fitness | |
|
Assaf Wand
Angel
|
2 | United States, Brazil, France | Seed, Series A, Pre-Seed | Insurance, Financial Services, FinTech | $2.8M–$42M |
|
Sake Bosch
Angel
|
2 | The Netherlands, France, Israel | Seed, Series A, Series B | Software, E-Commerce, Biotechnology | $1.9M–$77M |
|
Ron C
Angel
|
2 | Israel | Seed, Pre-Seed | Health Care, Therapeutics, Medical Device | |
|
Yaron Samid
Angel
|
2 | United States, Israel, Brazil | Seed, Pre-Seed, Series A | Software, Cyber Security, Artificial Intelligence | $2M–$47M |
|
Leonard Speiser
Angel
|
1 | Israel, United States | Seed, Pre-Seed, Series A | Information Technology, Video, Big Data | |
|
Rick Klausner
Angel
|
1 | United States, Israel, United Kingdom | Series A, Series B, Series E | Biotechnology, Therapeutics, Life Science | $30M–$47M |
|
Menachem Winfield
Angel
|
1 | Israel | Seed | Medical, Consumer Goods, Personal Health | |
|
Amir Gross
Angel
|
1 | Israel | Medical, Health Care, Medical Device | ||
|
Ole T. Jensen
Angel
|
1 | Israel | Biotechnology, Medical Device | ||
|
David E. Weekly
Angel
|
1 | United States, Israel | Seed, Angel, Pre-Seed | Robotics, Drones, Aerospace | |
|
Elad Ofer
Angel
|
1 | Israel | Series A | Consulting, Health Care, Professional Services | |
|
Haim Chizic
Angel
|
1 | Israel | Seed | Medical Device, Clinical Trials, Health Diagnostics | |
|
Shai Rephaeli
Angel
|
1 | Israel | Seed | Software, EdTech, Medical | $880k–$1M |
|
Rafi Benary
Angel
|
1 | Israel | Pre-Seed | Medical, Medical Device, Health Diagnostics | |
|
Moshe Shoham
Angel
|
1 | Israel | Pre-Seed | Medical, Health Care, Artificial Intelligence | |
|
Ron Doornink
Angel
|
1 | Israel | Series A, Convertible Note | Video, Computer, Health Care | |
|
Shane Neman
Angel
|
1 | United States, Kenya, Spain | Seed, Series A | Health Care, Software, Artificial Intelligence | |
|
David Agus
Angel
|
1 | Israel | Series A | Health Care, Health Diagnostics, Artificial Intelligence | |
|
Romain Afflelou
Angel
|
1 | France, United States, Israel | Seed, Series A, Pre-Seed | Health Care, FinTech, Software | |
|
Mandeep Singh
Angel
|
1 | United Kingdom, United States, Germany | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Information Technology | |
|
Amiad Solomon
Angel
|
1 | Israel, United States | Seed, Pre-Seed, Series A | Nutrition, Food Processing, Loyalty Programs | |
|
Yasmin Lukatz
Angel
|
1 | Israel | Seed, Pre-Seed | Medical, Consumer, Wellness | |
|
Raoul Stein
Angel
|
1 | Israel | Pre-Seed | Medical, Health Care, Therapeutics | |
|
Nir Greenberg
Angel
|
1 | Israel | Angel, Pre-Seed | Advice, Medical, Software | |
|
Lyndon Babtiste
Angel
|
1 | Israel | Seed | mHealth, Blockchain, Health Care | |
|
Edward Lando
Angel
|
1 | United States, France, United Kingdom | Seed, Pre-Seed | Software, Health Care, Information Technology | |
|
Brock Weatherup
Angel
|
1 | Israel, United States | Seed | EdTech, Medical, mHealth | |
|
Lewis Pell
Angel
|
1 | Israel, United States | Post-IPO Equity | Health Care, Medical, Therapeutics | |
|
Nir Kalkstein
Angel
|
1 | Israel | Seed, Series B | Machine Learning, Health Care, Artificial Intelligence | |
|
Ariel Yaar
Angel
|
1 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, Health Care, CRM | |
|
Zohar Zisapel
Angel
|
1 | Israel, United States | Series A, Seed, Series B | Cyber Security, Information Technology, Security | |
|
Nadav Lurie
Angel
|
1 | Israel | Series A | Consulting, Health Care, Professional Services | |
|
Chris Mansi
Angel
|
1 | United States, Israel | Series A | Health Care, Medical, Software | |
| Access all 140 angel investors in Israel Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Machine Learning
- Stage:Series A, Seed, Series B
- Geography: Israel, United States, Germany
Investor stats
- Total investments: 33
- Round size: Seed $3M–$120M; Series A $5M–$23M; Series B $8M–$83M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- CPTx — At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
- BioGenCell — Ushering in a New EraIn Cellular Medicine Making personalized cell-therapy a reality for every patient with a degenerative microvascular disease.
- 1E Therapeutics — 1E Therapeutics is a breakthrough, drug development company creating RNA-targeting therapeutics based on a proprietary drug design platform.
Ran Tuttnauer
Show more...Investment focus
- Industry: Health Care, Big Data, Internet
- Stage:Seed, Series A
- Geography: Israel, Canada, United States
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Innovopro — InnovoPro is committed to bringing unique plant-based protein ingredients to the global food market in order to create nutritious, tasty, safe, and sustainable food products. With an excellent nutritional profile, free from properties and wide usability in the food industry, InnovoPro’s chickpea protein is the best choice for the growingplant-based protein market.InnovoPro was founded on 2013 by Dr. Ascher Shmulewitz an experienced inventor and investor, and has made considerable progress in developing chickpea proteins and other chickpea ingredients.InnovoPro has been recognized as an innovator of disruptive technology in the food industry.
- Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
- Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders.
Howard Morgan is currently the Chairman of B Capital. He co-founded First Round Capital with Josh Kopelman as the first professional Seed Stage Fund, where he remains Senior Advisor. Prior to First Round, Howard helped found Idealab with Bill Gross, and served as President of Renaissance Technologies, which he co-founded with Jim Simons. Prior tohis move into the business of technology, Howard served as a professor at the Wharton School and the Moore School, both at the University of Pennsylvania, as well as at Cornell University. He is also an Executive Fellow at UC Berkeley. Howard’s research on user interface technology and the optimization of computer networks was critical to bringing the ARPAnet to Philadelphia in the 1970s. Through this early internet participation, he helped corporate and government agencies use technology to improve the efficiency of both large and small organizations. He also has deep experience with very large databases, and served as the first Editor of the ACM Transactions on Database Systems Journal. Throughout his career, Howard has sought out great people and nurtured them so that they could realize their dreams. His mentees have included both PhD students researching a key topic, and early stage entrepreneurs building companies and taking them from seed stage through initial public offerings. He currently serves as a Director of Idealab, and he is on the board of several non-profits including Cold Spring Harbor Laboratories and Math For America. He has also served on a number of public company Boards, including Franklin Electronic Publishers and Internet Brands, Inc. He was CEO of Kentek and Franklin during various turnover or transitional periods and in 1997 he was named Delaware Valley Entrepreneur of the Year. Howard is a respected author and a frequent speaker at major industry conferences. Howard received a PhD in Operations Research from Cornell University in 1968, and a BS in Physics from City College of the City University of New York in 1965.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, India
Investor stats
- Total investments: 81
- Round size: Seed $1.2M–$7.3M; Series A $2M–$85M; Series B $857k–$28M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- LexCheck — Transform your contract negotiation process with AI. Review, redline and approve contracts quickly and economically with the power of automation.
- Aktivate — Aktivate provides a SaaS based tecnology platform for K-12 schools to manage and fund scholastic sports. The system features administration and engagement tools to bring together student-athletes, their families, schools, and valued partners.
- NeuroKaire — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.
Show more...Investment focus
- Industry: Software, Internet, Health Care
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 34
- Round size: Seed $1.5M–$9.3M; Series A $1.6M–$11M; Series B $4.5M–$15M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- CADY — CADY's mission is to fully automate the inspection and verification of Printed Circuit Board (PCB) schematics, using AI technology.
- Hoopo — Hoopo assists companies to boost their logistics operations with cost and power-efficient, LPWA tracking solutions
- Body Vision Medical — Bronchoscopy, reimagined. Using Artificial Intelligence, the Body Vision Platform delivers real-time imaging without the use of electromagnetic sensors.
David Golan is the Co-Founder and Board Member at Viz.
Show more...Investment focus
- Industry: Health Care, Software, Wellness
- Stage:Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- NeuraLight — Brain function, quantified.
- Gradient Health — Gradient Health provides instant access to 19M+ de-identified medical images for AI/ML developers and research teams worldwide.
For the last 10 years, I have been active within the Israeli and US startup ecosystems where I completed 20+ seed investments in companies such as Geoforce (acquired by LLR), Bonobo (acquired by Salesforce), Optitex (acquired by Efi), Keeprz (acquired by Como), Drippler (acquired by Soluto), Snyk (Unicorn) and few others. I am passionate for seedinvestments, creative ideas, risk taking and supporting entrepreneurs.Prior to that, I founded 2 companies, Blue Sky (Energy) and Sinusafe (Medical) after working as a software engineer for 7 years.I grew up in Israel, and lived in the US for 5 years while completing my MBA from Duke. I love all kinds of extreme sports, and particularly kite surfing and snowboarding.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Internet
- Stage:Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 23
- Round size: Seed $65k–$11M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Laxis — Learn how UX designers, product managers, market research, consultants, and attorneys use conversation Intelligence to supercharge their business and increase revenue. Learn more.
- Deci AI — Deci enables deep learning to live up to its true potential by using AI to build better AI. With the company’s end-to-end deep learning acceleration platform, AI developers can build, optimize, and deploy faster and more accurate models for any environment, including cloud, edge or mobile. With Deci’s platform, developers can increase deeplearning model inference performance by 3x-15x, on any hardware, while still preserving accuracy. This translates directly into new use cases on limited hardware, substantially shorter development cycles, and reduced compute costs by up to 80%. The platform is powered by Deci’s Automated Neural Architecture Construction (AutoNAC) technology, an algorithmic optimization engine that squeezes maximum utilization out of any hardware. The AutoNAC engine contains a Neural Architecture Search (NAS) component that redesigns a given trained model’s architecture to optimally improve its inference performance (throughput, latency, memory, etc.) for specific target hardware while preserving its baseline accuracy. Deci achieved a record-breaking 11.8x accelerated inference speedup on Intel CPUs at MLPerf Industry Benchmark and has been named to the CBInsights top 100 AI companies. Led by a team of world-class deep learning experts, Deci lets AI developers focus on what they do best - creating innovative AI-based solutions for our world’s most complex problems.
- Velocity — Accelerate the way you build and deliver products. Spin up fully isolated, production-like environments in seconds. Work with your existing dev toolbox.
Avishai Abrahami is our Co-Founder, has served as our Chief Executive Officer since September 2010 and was our Co-Chief Executive Officer and a director since October 2006. From 2004 to 2006, Avishai was the Vice President of Strategic Alliances at Arel Communications & Software Ltd., a private Israeli company specializing in communicationtechnology. In 1998 he co-founded Sphera Corporation, a private company which develops software for managing data centers, and he served as its Chief Technology Officer from 1998 until 2000 and its Vice President of Product Marketing from 2000 until 2003. In 1993, he co-founded AIT Ltd., a private Israeli software company, and served as its Chief Technology Officer until the company's sale in 1997. Avishai served in the Israeli Defense Forces' elite computer intelligence unit from 1990 until 1992.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Italy
Investor stats
- Total investments: 19
- Round size: Seed $250k–$8M; Pre-Seed $1.2M–$7M; Series A $13M–$35M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Willow — The AI basecamp for the enterprise.Willow (formerly Webrix) connects any AI agent (Claude, ChatGPT, Cursor) to your internal systems with the visibility security needs and the enablement teams want. SSO, RBAC, audit trail, and runtime guards, built in.You'll find: - Technical deep dives on MCP, agents, and AI governance - Enterprise AIadoption playbooks (not hype) - Real implementation walkthroughs from production deployments - Conversations with CISOs, platform leaders, and AI adoption ownersBuilt for: CISOs, VPs of Engineering, platform leads, and CTOs rolling out AI at scale.
- Marquee — Marquee AI is a Sports tech company that develops advanced AI platforms to analyze recruitment, scouting and performance of the player.
- CustoMED — CustoMed transforms surgical planning and execution. It does this by converting medical imaging into 3D visualizations, planning procedures, and producing customized 3D-printed surgical solutions at scale in a matter of minutes, all while streamlining the process and providing surgical excellence.
Business entrepreneur and investor in startups. For the past 20 years developer of new initiatives and ideas. CEO, Chairman of companies, political strategist and advertising expert. Lead public opinion campaigns for people and issues from breast cancer, to national elections to the Israeli-Palestinian peace negotiations. Founding Partner atmybulb.vcOwner of the Gaon Holding Group; Executive Director in the group's companies, focusing on development and marketing products and services for the global Water Smart Grid. Member of the AquaAgro Fund Investment committee, a 50 Million dollar Israeli Venture Capital Fund, focused only on developing innovative water and agriculture technologies, as well as other innovative clean technologies.
Show more...Investment focus
- Industry: Advertising, SaaS, Music
- Stage:Seed, Series A, Convertible Note
- Geography: Israel, United States
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Apester — Supercharge your marketing and funnel with interactive content experiences that generate more leads, engage and convert users, and boost retention
- Yoocan — Yoocan is a global community for people with disabilities and their families, discover empowering stories, find support, and connect with a world that understands you.
- IndieFlow — IndieFlow developed a workflow management platform for the music industry. The platform provides a centralized platform to manage music industry workflows and streamline the major building blocks of an artist’s career. It enables users to manage creative projects, distribute to streaming platforms, collect roylaties, register music with royaltycollection societies, promote music, book gigs, receive payments and more.
Eyal Gura is the Board Member of Imagene AI. He previously worked at Zebra Medical Vision Ltd as a Co-Founder, President and Chairman of the Board. Eyal Gura attended Reichman University (IDC Herzliya).
Show more...Investment focus
- Industry: Software, Mobile, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Belgium
Investor stats
- Total investments: 26
- Round size: Seed $1M–$3.6M; Series A $7.1M–$40M; Series B $14M–$21M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Taranis — Taranis offers cutting-edge crop & farm management software for precision agriculture. Increase efficiency and yield. Learn more now.
- Imagene AI — Imagene AI is a pioneer in multimodal foundation models for precision medicine, advancing translational research and clinical development. We make every trial more responsive, every insight more actionable, and every patient journey more personalized.
- MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
Principal at Awz Ventures | Advancing Israel’s Economic & Technological Resilience Investing in deep-tech innovations across AI, cybersecurity, photonics, biotech, and quantum technologies to strengthen Israel’s economy and defense capabilities. Veteran Staff Sergeant in the Israeli Air Force Intelligence division, Horizon. MSc BusinessAnalytics & BA Financial Economics, Psychology & Business Management; Columbia University Magna Cum Laude.• Former President and Founder of Democratize Value (VC) • Former President and Founder of The Iftach Consulting Group (Management Consulting)My recent accomplishments include: • Raising $8 million from angel investors and due diligence/investing in 27 ventures in PropTech, E-commerce, Marcom, Healthcare, and FinTech sectors • Providing fundraising, due diligence, marketing, and operational advice to 23 PropTech, FinTech, and other Israeli start-ups • Underwriting, modeling, sourcing capital, negotiating, and closing 100+ commercial real estate transactions in the US, Israel, and EuropeOn the personal side, I: • Created a documentary called “Survival In The Forest, Isidore Karten & The Partisans”. • Served in the Israeli Air Force (SSG in Business Intelligence Division) • Volunteer as a Board Member with Yad Va Shem and the Israeli American CouncilSkills Global Early-Stage Startups | Venture Capital| Business Valuation | Account Management | Arabic | Business Strategy | Data Analysis | Financial Reporting | Foreign Relations| Hebrew | Management Consulting | Public Speaking | Social Media | Statistical Data Analysis | Strategic Communications | Team Leadership | Arab-Israel Conflict | Business Valuation | Client-Focused | Customer Relationship Management (CRM) | Commercial Real Estate Acquisition | Commercial Real Estate Analysis | Commercial Real Estate Development | Competitive Analysis | Corporate Finance | Corporate Venture Capital| Creative Entrepreneurship | Early-Stage Investment | Early-Stage Ventures| Debt & Equity Capital Raising| Debt & Equity Financing | Entrepreneurship Development| Financial Analysis | Financial Modeling | Fintech| Fundraising | Global Cross Functional Team Leadership | International Business Development | International Trade Relations | Investment Communications | Management Due Diligence| Market Research | New Business Development |Operational Due Diligence| Private Equity Firms | Proptech | Real Estate Private Equity | Residential Real Estate Sales | Startup Development | Start-Ups | Valuation Modeling
Show more...Investment focus
- Industry: Software, B2B, Marketing
- Stage:Seed, Angel, Pre-Seed
- Geography: Israel, United States, Canada
Investor stats
- Total investments: 15
- Round size: Seed $150k–$10M; Pre-Seed $100k–$250k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MyQuest — myQuest enables you to engage customers and employees anywhere, anytime. Easily train and interact with learners using AI, micro-learning, and gamification.
- Immagnify Ltd. — Immagnify provides business teams with accurate B2B contact information based on advanced technographic segmentation and customer analysis.
- DayDream Ventures — DayDream Ventures is a venture fund investing in founders building with community-led growth in mind in.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mr. Yehuda Zisapel (EE,MSc, MBA, DHC) is the founder and president of the RAD-Bynet Group, a leading pioneering association of Israeli companies active in the development, production and marketing of innovative solutions for the data communications industry, and Chairman of RAD. The RAD-Bynet Group grew out of Bynet Data Communications, whichMr. Zisapel founded in 1975 as a small private company that marketed data communications products. Bynet represented major international vendors and was the first to introduce cutting-edge technologies into the Israeli market. Today, the Bynet Group is comprised of eight companies active in both the Israeli and Eastern European markets in such fields as systems integration, cabling, testing, outsourcing, and software development. Following the arrival of Mr. Zisapel’s brother, Zohar, who joined him in 1981, a wide range of industrial activity was spawned from within the newly established RAD, the first of the RAD Group companies. In the years following its successful launch, twenty-four additional independent hi-tech companies were opened to develop, produce and market a wide variety of advanced data communications products.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series A, Seed
- Geography: Israel
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Carteav — Autonomous Low Speed Vehicle
- Rewire — Secure financial services designed to help migrants make cross-border money transfers. Rewire offers great rates, fast delivery, multilingual customer support
- Laminate Medical — Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the firstyear. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications.
Entrepreneur at heart. Angel investor in past two decades. I had the privilege to invest in the following startups, mostly at seed level: Houzz(Unicorn), TripActions(Unicorn), Hippo(Unicorn), HomeLight, Domestika, Loop Commerce, RedKix, Duda, YouNow, OwnerListens... But mostly, I am known as Oren from Oren's Hummus :)
Show more...Investment focus
- Industry: FinTech, Payments, Software
- Stage:Seed, Series A, Angel
- Geography: United States, Israel
Investor stats
- Total investments: 13
- Round size: Seed $1M–$17M; Series A $2M–$11M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Linguana — Linguana builds and monetizes your fully localized YouTube channels in new languages to reach new audiences across the globe and monetize them.
- Openbase — Find and compare the best open-source packages in hundreds of categories - withpowerful metrics and user reviews
- Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
Mazal CB
Show more...Investment focus
- Industry: Health Care, Therapeutics, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Ronald Cohen is Chairman of the Global Social Impact Investment Steering Group and The Portland Trust. He is a co-founder director of Social Finance UK (2007-11), Social Finance USA, and Social Finance Israel, and of Big Society Capital. He was co-founder Chair of Bridges Ventures (2002-2012).He chaired the Social Impact Investment Taskforceestablished under the UK’s presidency of the G8 (2013-2015), the Social Investment Task Force (2000-2010) and the Commission on Unclaimed Assets (2005-2007). In 2012 he received the Rockefeller Innovation Award for innovation in social finance.He co-founded and was Executive Chairman of Apax Partners Worldwide LLP (1972-2005). He was a founder director and Chairman of the British Venture Capital Association and a founder director of the European Venture Capital Association.He is a graduate of Oxford University, where he was President of the Oxford Union. He is an Honorary Fellow of Exeter College, Oxford. He has an MBA from Harvard Business School to which he was awarded a Henry Fellowship.He is a member of the Board of Dean’s Advisors at Harvard Business School and Vice-Chairman of Ben Gurion University. He is a former director of the Harvard Management Company and the University of Oxford Investment Committee. He is a former member of the Harvard University Board of Overseers (2007-2013), former Trustee of the British Museum (2005-2012) and a former trustee of the International Institute for Strategic Studies (2005-2011).In 2007, Sir Ronald published: “The Second Bounce of the Ball – Turning Risk into Opportunity”.
Show more...Investment focus
- Industry: Health Care, Financial Services, Apps
- Stage:Series A, Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 21
- Round size: Seed $8M–$100M; Series A $1.7M–$30M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Selina — Stay in stylish accommodations with vibrant spaces, community-driven events, and unforgettable experiences. Book your Socialtel adventure today!
- Opmed.ai — Address OR resource shortages with OpMed. Optimize OR scheduling with AI for maximum efficiency, reduced costs, and better patient care.
- Glide Identity — Transform your digital security with Glide Identity's AI-powered authentication suite. Our solutions - Magical Auth, Smart Checkout, and That's Me - deliver unmatched security with seamless user experience
Jordan Feiger
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VeinWay — VeinWay is a medical device firm that develops a catheter for recanalizing chronic venous occlusions due to blockage or disease.
Prof. Rafael Beyar
Show more...Investment focus
- Industry: Medical Device, Medical, Machine Learning
- Stage:Series A, Seed
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Series A $1M–$17M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
Shimon Eckhouse
Show more...Investment focus
- Industry: Medical, Biotechnology, Fitness
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Epitomee Medical — Epitomee develops paradigm-shifting ingestibledevices that deploy targeted therapies along the GI tract
Assaf Wand is the Founder and Executive Chairman of Hippo Insurance. He previously worked at Sabi Sold to Urbio as a Founder and CEO. Assaf Wand attended the University of Chicago.
Show more...Investment focus
- Industry: Insurance, Financial Services, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Brazil, France
Investor stats
- Total investments: 14
- Round size: Seed $2.8M–$15M; Series A $8M–$42M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Segura — Segura equips brokers with tech and top insurer access for the future of insurance.
- Advance — Insurance Financials Operations that Pay You.
- Carecode — Carecode system combines powerful Generative AI models with continuous learning mechanisms, enabling natural and autonomous interactions that adapt to complicated environments without the need for human intervention.
Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.
Show more...Investment focus
- Industry: Software, E-Commerce, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: The Netherlands, France, Israel
Investor stats
- Total investments: 32
- Round size: Seed $1.9M–$9.5M; Series A $6.9M–$29M; Series B $7.1M–$77M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- TerraSpark — TerraSpark Energy specializing in software solutions for renewable energy asset management. The product, TerraSpark Hub, provides comprehensive oversight of commercial and technical data for green energy assets like solar and wind projects.
- Recupere Metals — Recupere Metals focused on recycling copper scrap into high-quality electrical wires. It uses a patented mechanical process enhanced by AI to boost conductivity from impure scrap, bypassing energy-intensive smelting.
- A&B Smart Materials — The A&B Smart Materials Using innovative cooling technologies to boost photovoltaic efficiency.
Ron C
Show more...Investment focus
- Industry: Health Care, Therapeutics, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Yaron Samid is an Israeli-American technology entrepreneur, investor, and startup community builder. Yaron is the founder of TechAviv, the 3K-member global Israeli startup founders club, and is the managing partner of TechAviv Founder Partners, a pre-seed venture fund, backed and powered by over 100 of the world’s most successful company builders.Previously, Yaron was the founder and CEO at BillGuard (Acq. by Prosper), founder & CPO at Pando (Acq. by Microsoft), and a founding board director at CloudLock (Acq. by Cisco) and Pond5.Yaron lives in Tel Aviv with his family and is a regular guest lecturer at Stanford and Columbia Business School. He attended Technion - Israel Institute of Technology and the University of Maryland.
Show more...Investment focus
- Industry: Software, Cyber Security, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Israel, Brazil
Investor stats
- Total investments: 23
- Round size: Seed $4M–$20M; Pre-Seed $2M–$10M; Series A $9M–$47M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Emedgene — Applying machine learning to genomics. Accelerate NGS data analysis and automate variant classification with evidence curated from the literature. From sample to report.
- Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
- Together AI — Together will enable researchers, developers & companies to leverage and improve artificial intelligence with an intuitive data, models & computation platform.
Leonard Speiser is the Founder of Horizon 3.
Show more...Investment focus
- Industry: Information Technology, Video, Big Data
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aside — Aside is the company that builds cloud-based platforms. Daffy Charitable is its first not-for-profit community platform.
- MoBagel — MoBagel’s vision is to bring AI-driven decision making to enterprises through software and services. MoBagel has empowered global enterprises to extract business insights and create value from their data across industries including retail, telecom, manufacturing, banking, and more.
- Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.
Rick Klausner is a Chief Executive Officer at Lyell Immunopharma.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Life Science
- Stage:Series A, Series B, Series E
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 9
- Round size: Series A $30M–$47M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
- Hippocratic AI — The First Safety Focused LLM for Healthcare
- LifeMine Therapeutics — What if the solutions to the greatest unsolved medical problems of our time had already been evolved in nature, hiding in plain sight as molecules waiting to be mined? What if revolutionary discoveries in emerging scientific fields from gigascale DNA sequencing to artificial intelligence and synthetic biology had advanced, such that we finally had a way to mine the biosphere and bring transformative new medicines to patients in need? Our answers to these questions drive the passion and mission at LifeMine Therapeutics.
Menachem Winfield is the founder and Managing Director of Starry Group. He previously worked at Seebo as an Advisor.
Show more...Investment focus
- Industry: Medical, Consumer Goods, Personal Health
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
Amir Gross is the CEO of Cardiovalve.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- BrainQ — BrainQ is developing breakthrough precision neurology therapies using Brain Computer Interface technology....
Ole T. Jensen
Show more...Investment focus
- Industry: Biotechnology, Medical Device
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Nobio — NobioTM developed game-changing technology with the goal to prevent medical device contamination indefinitely, as the first and only fully-integrated anti-biofilm solution. The technology core consists of extremely potent particles which are covered with a high concentration of highly-active anti-microbial structures that kill bacteria uponcontact. The NobioTM particles can be permanently embedded in many products and materials to inhibit formation of biofilm, indefinitely.
David E. Weekly is the Head of The Capital One Lab of Capital One. He previously worked at Medcorder as a Founder and CEO. David E. Weekly attended Stanford University.
Show more...Investment focus
- Industry: Robotics, Drones, Aerospace
- Stage:Seed, Angel, Pre-Seed
- Geography: United States, Israel
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Mast Reforestation — No-cost reforestation for post-wildfire burned acreage for landowners and foresters, funded by carbon removal credits.
- Sugarlogix — A precise reflection of human milk to provide the best nutrition for babies
- Mast Reforestation — No-cost reforestation for post-wildfire burned acreage for landowners and foresters, funded by carbon removal credits.
Elad Ofer is the Product & Operations Manager.
Show more...Investment focus
- Industry: Consulting, Health Care, Professional Services
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Droxi — Droxi is an AI-based platform that helps primary care physicians to reduce the amount of time spent on non-patient-facing tasks.
Haim Chizic is an individual investor.
Show more...Investment focus
- Industry: Medical Device, Clinical Trials, Health Diagnostics
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Shai Rephaeli - Co-Founder and CEO @ Tutoria Digital
Show more...Investment focus
- Industry: Software, EdTech, Medical
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Round size: Seed $880k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Myndlift — Myndlift offers a therapist-guided home neurofeedback solution for mental health, using mobile and wearable technology. Home users enjoy accessible and affordable training while neuro-therapists can grow their practices with remote supervision.
- Lingua.ly — Founded by Cambridge and Stanford graduates Dr. Jan Ihmels and Dr. Orly Fuhrman, Lingua.ly is a brand new way to learn a language. Collect new words from across the web with Lingua.ly's smart dictionary. Use your new vocab as you read real articles you choose. Immersion is the ultimate way to learn a language, and Lingua.ly’s free, onlinelearning platform uses “digital immersion” to give you all the same benefits no matter where you learn. Do you like to read about science and technology in your spare time? Prefer French recipes or travel magazines? Perhaps following business updates from the Middle East is key to your company’s success? Our patent pending algorithm understands your vocabulary to fill your feed with real articles from the web to suit both your level and interests. Better still, we let you practice your new words through fun games and quizzes. So, give your vocabulary a boost, create some colorful flashcards, keep your mind engaged and explore the web in a new language with Lingua.ly! Learn English, French, Spanish, Arabic, Hebrew, Dutch, Italian, Portuguese, German and Russian. Lingua.ly’s blended learning solution can be used as a stand-alone product or to complement language classes and self-study course-ware. It is cloud synced and operable via desktop or mobile and supports 18+ dictionary languages. Website: http://lingua.ly App Store: http://bit.ly/1pyL1bb Google Play: http://bit.ly/1s04YuK
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Rafi Benary is the Co-founder at Innoventric and he holds a Masters’ degree from the New York University in Material Science and a Mechanical Engineering. He is an entrepreneur of 4 start-up companies, bringing them from inception to clinical stage through effective planning and execution.
Show more...Investment focus
- Industry: Medical, Medical Device, Health Diagnostics
- Stage:Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Althea Medical — Althea Medical is a creator of catheter devices for the treatment of patients with sub- or major pulmonary emboli. The company is developing a catheter-based solution for treating patients suffering from massive and sub-massive Pulmonary Embolism (PE). Althea Medical was established in 2020 in Tel Aviv, Israel.
Moshe Shoham
Show more...Investment focus
- Industry: Medical, Health Care, Artificial Intelligence
- Stage:Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Predicta Med — Predicta Med is a decision support platform for early detection and intervention selection of autoimmune diseases. Our platform gives healthcare providers an AI-powered method for shortening the diagnostic process of identifying autoimmune diseases and by that could enhance provider’s efficiency, improve treatment effectiveness and patient'scare. A process which typically takes more than four years and at least four different doctors can be shortened significantly using our platform.
Ron is an Operating Partner with Stripes Group, primarily focused on evaluating and supporting branded consumer products and consumer technology businesses.Ron currently serves as chairman of Turtle Beach Inc., a Stripes Group portfolio company and leading provider of headsets for gaming devices like the Xbox, PlayStation,Wii and PC, as well asmobile devices such as tablets and smartphones. In addition, Ron is founder and principal of Erasmus Equity Investments and serves as an advisory board member of Jawfish Games. He is also a member of the board of overseers of Columbia Business School, and a board member of the Prevent Cancer Foundation. His past associations include being an advisor to the board of directors of Activision-Blizzard, member of the board of directors of Activision, president of Activision, chairman and chief executive officer of Activision Publishing, and president of Hunt-Wesson Snack Food, a division of ConAgra Foods. Earlier, he held progressive positions in marketing and general management with Procter & Gamble.Ron lives in Manhattan Beach California, is a dual citizen (USA and the Netherlands) and he is married with four children.
Show more...Investment focus
- Industry: Video, Computer, Health Care
- Stage:Series A, Convertible Note
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.
Founder of EZ Texting and JoonBug. Serial entrepreneur and investor in Tech, Real Estate & Hospitality.cA forward-thinking problem solver, consummate optimist and serial entrepreneur, Shane Neman is the prototypical businessman of our modern era. His experience and expertise in business span numerous industries, from technology andtelecommunications to real estate and hospitality. After leaving NYU Medical School early, he started three industry-shifting tech startups (two of them – EZ Texting and JoonBug – acquired) with hundreds of employees and tens of thousands of customers. As an insightful startup backer, Shane’s portfolio includes companies such as Convoy, Prose, Impossible Foods, Universal Standard, Apostrophe, MeetMindful, MapAnything, VinePair and Smylen. Shane is also a prolific real estate developer and investor. From commercial shopping and industrial centers to residential buildings, he owns more than two dozen large-scale properties across the U.S. He holds a degree in Computer Science from New York University, where he received the prestigious Barry M. Goldwater scholarship and was a member of the Phi Beta Kappa academic honor society.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Series A
- Geography: United States, Kenya, Spain
Investor stats
- Total investments: 98
- Lead/follow: no public data
Portfolio highlights
- Endiatx — Endiatx is a medical device manufacturing company that specializes in developing a series of pill-sized robots to perform remote diagnosis. Its unique propulsion system which allows our pill robots to actively navigate the entire length of the GI tract is approximately 30 minutes with real-time video control.It was founded in 2019 andheadquartered in Redwood City, California.
- Nara Organics — Introducing a whole new standard for infant formula. Nara Organics is built on the healthy fats in organic whole milk.
- SpaceX — SpaceX designs, manufactures and launches advanced rockets and spacecraft.
Dr. David B. Agus is one of the world’s leading doctors and pioneering biomedical researchers. He is the founding director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine and a professor of medicine and engineering at the University of Southern California. A medical oncologist, Dr. Agus leads a multidisciplinary team ofresearchers dedicated to the development and use of technologies to guide doctors in making health-care decisions tailored to individual needs. An international leader in global health and approaches for personalized healthcare, Dr. Agus serves in leadership roles at the World Economic Forum and is co-chair of the Global Health Security Consortium. He is also a CBS News contributor. Dr. Agus’ three books The End of Illness, A Short Guide to a Long Life, and The Lucky Years: How to Thrive in the Brave New World of Health, are all New York Times and international bestsellers, with a new book, The Book of Animal Secrets: Nature’s Lessons for a Long and Happy Life, set for release in March 2023. He is a 2017 recipient of the Ellis Island Medal of Honor.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Artificial Intelligence
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Imagene AI — Imagene AI is a pioneer in multimodal foundation models for precision medicine, advancing translational research and clinical development. We make every trial more responsive, every insight more actionable, and every patient journey more personalized.
Romain spearheaded the digital strategy of Alain Afflelou Group before becoming an investor in numerous start-ups. He uses his fine-tuned analysis skills to support and invest in innovative start-ups. In addition to being a major shareholder and Co founder of Cosmo Connected a French start-up specialized in connected objects related to security andmobility.Romain is Director and Board member of Multiwave Technologies /develops breakthrough metamaterial technologies to improve people's lives.Serial investor in +50Tech companies6over6 (Acquired by 1-800 contacts) Cityscoot Clay Inc VR Cowboy Bike Epicery Everoad (Ex Convargo) Fithouse Fré Skincare Fokoya Guillotine Vodka Klassroom Laminate Technologies MeetFabric Molotov TV Multiwave Technologies Nestor Octopus Officeriders Onoff telecom Pledg Quiqup Universal Standard Shapr Spendesk Zipdrug...(Acquire by Anthem Pharmacy)
Show more...Investment focus
- Industry: Health Care, FinTech, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: France, United States, Israel
Investor stats
- Total investments: 30
- Lead/follow: no public data
Portfolio highlights
- Cashbee — Cashbee is a mobile application to helps save money with budget analysis tools based on artificial intelligence. They wish to help the French to save better and more, and to provide the technological means to do this in the simplest possible way, without having to change banks. The Cashbee App allows you to put money aside with a simple swipe onyour smartphone. They alert you every time when they think you can put some more cash aside.
- Kate — Kate redefines everyday mobility by offering electric vehicles made in France.
- Kubo Labs — Kubo Labs provides a suite of products to simplify your experience with Kubernetes.
Mandeep Singh is an Angel investor at multiple firms. He previously was the founding CEO at Trouva. Mandeep Singh studied Physics at the University of Cambridge.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 74
- Lead/follow: no public data
Portfolio highlights
- Droidrun — Droidrun is a cutting-edge software development company that specializes in creating innovative solutions enabling AI agents to seamlessly access and control smartphone applications. By leveraging advanced artificial intelligence and machine learning algorithms, their software facilitates smooth interactions between AI systems and mobile devices,empowering agents to autonomously navigate, operate, and optimize a wide range of apps on both Android and iOS platforms.
- Stackfix — Stackfix operates as a software comparison platform.
- Fractile — Fractile is designing AI compute systems that will enable the next generation of AI scaling: frontier model inference, 25x faster, at 1/10th the cost.
Amiad Solomon is the CEO and Founder of HQ. He previously worked at Komoona as a Founder and Chairman.
Show more...Investment focus
- Industry: Nutrition, Food Processing, Loyalty Programs
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Remilk — Remilk is a food-tech company that uses microbes to produce the key ingredients in milk. The company is developing technology for creating a milk substitute that is similar to cow milk in flavor, nutritional composition, composition, and functionality. It was founded in 2019 and is based in Tel Aviv, Israel.
- Snowmate — Snowmate's disruptive technology finds backend bugs fully automatically and at the earliest stages of the development cycle - no AI, no magic tricks, but pure deep tech only.
- ANYBODIES — Anybodies is the first enterprise customer engagement platform for creating NFT based loyalty programs for creators, brands and enterprises.
Yasmin Lukatz is the Founder and Executive Director of ICON. She attended Stanford Graduate School of Business.
Show more...Investment focus
- Industry: Medical, Consumer, Wellness
- Stage:Seed, Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
- Arya — Arya is building the Couples Wellness category, poised to become the next billion-dollar cornerstone in the global wellness market.Couples are falling into routine and many are experiencing increased loneliness. While billions are spent on fitness, mindfulness, and sleep, emotional and physical intimacy is often neglected. We invest in swipingfor the right partner and then trying to fix it (or spend a fortune divorcing them)... but not much in between.Arya's AI concierge makes it radically easy for couples to invest in their relationship and love life, both inside and outside the bedroom - a crucial ingredient to a successful relationship.
- PointFive — PointFive provides ongoing cloud cost savings by providing deeper detection and collaborative repair solutions that fit smoothly into teams' normal operations.
Raoul joined Kreos in 1999 and over the last 12 years has built a highly active presence as the leading senior credit provider to high-growth companies in Israel, as well as supporting a wide range of transactions across Europe. Mr. Stein also plays a key role in the management and execution of Kreos's overall strategy.Before joining Kreos,Raoul was an associate with Apax Partners in Israel where he invested in services and high-growth technology businesses and corporate spin-offs. He also assisted the general partners in fund-related activities such as divestment of their funds' successes traded on NASDAQ, and in general fund-raising activities such as portfolio analysis, reporting and due diligence for the purpose of raising new funds.Prior to joining Apax Partners, Raoul was an associate with Friedman , Turbidy & Co, a New York-based financial advisory firm. Raoul assisted the managing partner in several refinancing and acquisition transactions. He was involved in a refinancing of asset-backed loans with a large glass maker in the US, representing the company in its efforts to refinance its debt with banking institutions. In addition he was involved in fund-raising for a US based cosmetics company in its expansion.Raoul studied law at Bar-Ilan University. He clerked at the firm of M. Porath & Co in Tel-Aviv and passed the Bar exams in Israel in 1993. After that he graduated in 1995 from Columbia Business School with an MBA.
Show more...Investment focus
- Industry: Medical, Health Care, Therapeutics
- Stage:Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Pery — Pery empowers primary care providers to deliver better mental health care, boost revenue, and reduce administrative burdens. Learn more.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Founder and CEO at Natural Intelligence.
Show more...Investment focus
- Industry: Advice, Medical, Software
- Stage:Angel, Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Pery — Pery empowers primary care providers to deliver better mental health care, boost revenue, and reduce administrative burdens. Learn more.
- Superfy — Superfy gets you an answer to any question from a relevant person, using superior AI for matching people.With Superfy getting answers is simple. You ask a question, and Superfy connects you in chat with another user who already knows the answer. If you want to know the weather or exchange rates - go to Google; if you want to know what’s it liketo work at Google - ask Superfy!Superfy’s Machine Learning algorithms (US utility patent-pending) replace traditional NLP methods to crack the challenge of analyzing unstructured User Generated Content across all verticals.We launched our public iOS beta last December, and the stats are promising: 87% of our users are asking questions, 46% of our users are answering questions - over 10x the industry standard! Our users love Superfy, spending 9 minutes a day on the app, and calling it “cool”, “addictive”, “super-friendly” and “helpful” (rated 4.4 on the US Appstore).Download (iOS): https://apple.co/2CZ3HjI Or search Superfy on the App Store.Superfy was founded by Gil Schoenberg and Michal Tamir, a married couple with years of startup experience in Business, Marketing and mostly Product, both for B2C and B2B. Among our advisors is Avishai Abrahami, Wix Founder & CEO, who paved the way for Israeli B2C startups.
Lyndon Babtiste
Show more...Investment focus
- Industry: mHealth, Blockchain, Health Care
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Proof Work — Proof puts patients medical data on a decentralized secure platform and ledger for personal ownership, interoperability and a lifetime history of care. For free. In two minutes your health data is secured on the blockchain. It's as easy as that.Our solution makes data more private and liquid costs less to administer and provides a real-timelifesaving flow of medical data.This same medical data becomes an intrinsic valuable digital passport arising from the users prerogative for permission-based access control.Rights can be granted or traded to either another patient, payer or provider such as doctor, insurer, hospital, pharmacy, nurse, caregiver, family or friend.
Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 311
- Lead/follow: no public data
Portfolio highlights
- Swaive — Swaive operates a financial firm that invests in risk-free instruments. The organization allows you to park your money without risk.
- Volta — Volta is a developer of software-as-a-service platform focusing on B2B commerce.
- Hidden Studios — Hidden Studios develops and advertises Fortnite Creative games, with 100M+ plays monthly. The company collaborated with prominent brands and creators, including Skydance, Snoop Dogg, and CaseOh, to deliver engaging gaming experiences. Hidden Studios maintains an active presence on YouTube, sharing content related to their Fortnite Creativeendeavors.
Brock Weatherup is the CEO/Founder of Metamorphosis Partners driving enterprise value through innovation in the $80B pet industry focused on the consumer. Brock was most recently the EVP of Strategic Innovation & Digital Experience at Petco. Previously he was CEO & CoFounder of PetCoach (acquired by Petco) - revolutionizing the PetHealth Care experience. Brock is a CEO, entrepreneur, angel investor, builder of enterprise value and passionate advocate about the consumer and their interactions with digital media & Ecommerce. Brock is also managing partner of Atai Ventures angel investments, co-founder of ICONYC (www.iconyclabs.com) an early stage NYC based Israeli accelerator, investor/advisor/board member for 7+ startups - VeryApt, SideCar, Social Ladder, Ethology and an industry advisor for VC firms EQT Partners, MissionOG & SafeGuard. Previously Brock was SVP/Chief Digital Officer of Petsmart after selling Pet360 where he was CEO the prior 5 years. Brock was also CEO of Fathead and held several leadership positions with InterActiveCorp (Ticketmaster, Match.com, CitySearch, ReserveAmerica). A graduate of University of Colorado Boulder, sits as a board member of the Nature Conservancy – Adirondacks, father of two amazing girls and pet owner to my 4yr old retriever named...Boulder.
Show more...Investment focus
- Industry: EdTech, Medical, mHealth
- Stage:Seed
- Geography: Israel, United States
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Myndlift — Myndlift offers a therapist-guided home neurofeedback solution for mental health, using mobile and wearable technology. Home users enjoy accessible and affordable training while neuro-therapists can grow their practices with remote supervision.
- Amplio — Discover Amplio's innovative platform for speech-language and dyslexia interventions. Streamline educator workloads with evidence-based programs and real-time progress monitoring, ensuring every student receives the individualized support they need.
Lewis Pell was appointed to our Board of Directors and was unanimously elected to serve as Non-Executive Chairman of the Board on December 12, 2011. Pell was a member of Radiancy’s Board since 1998. Pell has founded over a dozen successful medical technology companies during the past three decades. In 1979, he founded Pentax PrecisionInstruments, which was sold to Asahi Optical Co. in 1990. In 1983, he founded American Endoscopy Inc., which was sold to C.R. Bard, Inc. (BCR-NYSE) in 1986. In 1984, he founded Versaflex Inc., which was sold to Medtronic in 1988. In 1989, he founded Heart Technology Corp., which went public in the U.S. in 1992 and was sold to Boston Scientific Corp. (BSX-NYSE) in 1995. In 1991, he founded InStent Inc., which became a public company in 1995 and was sold to Medtronic in 1996. In 1994, he founded Influence Inc., which was sold to American Medical Systems Inc. in 1999. Working with Shlomo Ben-Haim, Pell founded Biosense Inc. in 1994, which was sold to Johnson & Johnson in 1997. He is currently chairman and an investor for a number of private medical device companies. In 1992, he founded and remains the chairman of Vision-Sciences, Inc. (VSCI-NASDAQ). Pell has a B.S. in political science from Brooklyn College and over 20 years of experience in the medical technology industry. Pell was selected to serve on the Company’s board because of his over thirty-years’ experience in leadership roles in the medical device industry.
Show more...Investment focus
- Industry: Health Care, Medical, Therapeutics
- Stage:Post-IPO Equity
- Geography: Israel, United States
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
- Vision Sciences — Vision-Sciences, Inc., is a medical device company. The Company designs, develops, manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, EndoSheath technology. The Company produces and markets Endoscopes, such as cystoscopes, ureteroscopes, laryngoscopes,otoscopes, sinuscopes, trans-nasal esophagoscopy (TNE) and bronchoscopes for medical use and borescopes for industrial use, and digital processing units (DPU). The Company offers Urgent PC Neuromodulation System, a nerve stimulation device that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). It also offers Macroplastique, an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence. It markets additional bulking agents: PTQ for the treatment of fecal incontinence and the VOX for vocal cord augmentation.
Nir Kalkstein is an entrepreneur, a data scientist and a recognized expert in Big Data and machine learning algorithms. Nir co-founded Final, one of the most successful algo-trading companies worldwide. In 2009 He co-founded Medial with the vision of creating data-driven best-in-class predicative tools that provide physicians with actionableinsights to save lives. Nir has devoted significant intellectual and financial resources to support the ongoing success of the research for the Company, initially as the sole financier, and is committed to reinvesting his future profits into further research. Nir holds a BSc in Electrical Engineering from the Israeli Technion Institute of Technology.
Show more...Investment focus
- Industry: Machine Learning, Health Care, Artificial Intelligence
- Stage:Seed, Series B
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Nucleai — Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.
- Medial EarlySign — Medial EarlySign develops an AI algorithmic platform for the discovery of clinical insights that indicate the likelihood of disease from basic medical information, such as blood test results, and other EMR data. Called AlgoMarkers, its predictive engines are built in collaboration with healthcare organizations, through the combination of 10s ofmillions of patient years-worth of data, clinical rigor and some of the most brilliant algorithmic minds. The company develops clinical decision support and population health solutions that can assist in the early prediction of clinical outcomes related to cancers, metabolic, immune and infectious diseases. These tools are designed to place at the fingertips of healthcare organizations only those insights that could prove critical in disease management and prevention empowering them with proactive, predictive and personalized care management capabilities
Ariel Yaar - VP Research and Development @ Readz
Show more...Investment focus
- Industry: Software, Health Care, CRM
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- GearEye — Gear Eye: the ultimate tracking solution for your gear. Manage and locate your equipment tagged with battery-free RFID tags and stickers. Never lose your items.
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
- BioChange Ltd. — BioChange has developed a breakthrough technology for tissue regeneration.
Zohar Zisapel
Show more...Investment focus
- Industry: Cyber Security, Information Technology, Security
- Stage:Series A, Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 27
- Lead/follow: no public data
Portfolio highlights
- Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
- Nucleix — OUR TESTS AIM TO DETECT CANCER EARLIER - WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS
- Hailo — Hailo have developed the best performing AI processors for edge devices. Our AI accelerator chips are used for Smart City & Homes, machine learning, automotive AI, retail AI and smart factory Industry 4.0 solutions.
Nadav Lurie is the Employee at LURIE PROJECTS.
Show more...Investment focus
- Industry: Consulting, Health Care, Professional Services
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Droxi — Droxi is an AI-based platform that helps primary care physicians to reduce the amount of time spent on non-patient-facing tasks.
Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, buildingand supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series A
- Geography: United States, Israel
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Canopy — Canopy's intelligent care platform enables practices to improve cancer patients' experience and outcomes in an ever changing oncology environment.
- HumanFirst — HumanFirst enables better integration and analysis of digital health technologies in clinical trials.
- NeuraLight — NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care.
Health Care Angel investor funding in Israel at a glance
Stats across 130 deals from 140 investors.
Access all 140 angel investors in Israel Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care Angel Investors in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 140 angel investors investing in Israel Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!